
General Proximity
General Proximity is a YC Winter 2020 (W20) company. Based in San Francisco, CA, USA. Team of 15.
About General Proximity
Summary
General Proximity builds a platform for discovering and developing proximity-based medicines, targeting proteins previously considered undruggable. Its core engine systematically identifies effector proteins, the cellular machines that regulate other proteins through physical proximity, and uses them to control the function of a given disease target. This replaces the conventional approach of searching only for small-molecule binding pockets, opening therapeutic possibilities across a far broader range of targets.
Go-to-market
General Proximity works with academic medical centers and pharmaceutical partners to advance proximity therapeutics, operating through research collaborations rather than direct commercial sales.
From the Y Combinator listing
The next generation of induced-proximity medicines.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 15
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works